Parenteral Packaging Market

Parenteral Packaging Market: Prefilled Syringes and Bags to Collectively Account for More Than 55% of the Overall Market Value During the Forecast Period: Global Industry Analysis (2013-2017) & Opportunity Assessment (2018-2028)

  • 2018-08-29
  • REP-GB-1258
  • 195 pages
  • Format: PDF/PPT/Excel

An Incisive, In-depth Analysis on the Parenteral Packaging Market

This study offers a comprehensive, 360 degree analysis on the Parenteral Packaging market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Parenteral Packaging market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Parenteral Packaging Market Analysis: Over 35% of the Revenue to be Generated by the Pre-filled Syringes & Cartridges Product Type Segment in 2018, which is expected to increase further by the end of 2028 

The global market for parenteral packaging was valued at US$ 9,864.8 Mn in 2017 and is projected to expand at a CAGR of 4.8%, during the forecast period (2018 - 2028).

Parenteral packaging is a method that allows the medicine or other fluid to keep its potency and therapeutic effectiveness intact throughout the shelf life or till the time the drug is administered. Effective packaging in parenteral is required to protect the drugs from contamination and aseptic administration to the patient. Prefilled syringes and cartridges are certain novel innovations in the field of parenteral packaging, which favors minimization of drug administration, apart from conventional parenteral packaging solutions such as vials and ampoules. One of the key factors such as the introduction of various new raw material for parenteral packaging along with advancements in conventionally used materials are making the market more consolidated. There has been effective collaboration between the suppliers and manufacturers for raw material sourcing and final packaging. Introduction of polymers such as cyclic olefin copolymers (COC) and cyclic olefin polymers (COP) are acquiring the attention of many of the parenteral product manufacturers due to various advantages over plastic and glass. The introduction is beneficial for sophisticated and newly developed drugs and delivery technologies.

In terms of material, the plastic is expected to be the most attractive material segment for manufacturing parenteral packaging across the globe. Plastic is the most preferred material of choice for parenteral packaging due to their comparatively low cost an easy production method, advantages in terms of light weight, durability, no reactivity and design flexibility.

global-parenteral-packaging-market-report.jpg

Drivers & Restraints

Some of the key drivers for the growth of the global parenteral packaging market includes the increasing per capita healthcare expenditure of several leading economies across the globe. Parenteral drugs is the second-largest contributor to the global pharmaceutical market of US$ 962 Billion, with approximately 30% share in 2014, preceded only by oral dosage form. Moreover, the long-term estimates that pharma spending is expected to match the expenditure on healthcare sector at an average of 4.2% during the forecast period. Additionally, private health insurance (PHI) are playing significant role in carving up the healthcare systems. The overall impact of rise in per capita expenditure and introduction of health insurance are expected to favor the growth of parenteral packaging market. Immunizations through vaccines is a major health intervention that has a significant positive impact on the health the populace. Demand for parenteral is strongly correlated with immunization. Vaccination plans such as Global Vaccine Action Plan (GVAP) 2011–2020, National Vaccine Plan (NVP) by U.S., which are introduced by the government on regular intervals to eradicate health issues such as hepatitis, polio etc., are expected to further fuel the parenteral packaging market. According to World Health Organization (WHO) chronic non-communicable disease (NCD) prevalence is projected to grow by 57% between 2015 and 2020. In terms of geographical inclination of demand, emerging markets are expected to contribute significantly to growth, largely due to diseases related to lifestyle changes as well as population increase.

Market Taxonomy

The global market for parenteral packaging is segmented as per product type, material type, and its packaging type.

As per product type, the global parenteral packaging market is segmented as follows:

  • Vials

  • Pre-filled Syringes & Cartridges

  • Bags

  • Ampoules

  • Ready to Use Systems

As per material type, the global parenteral packaging market is segmented as follows:

  • Glass

  • Plastic

    • Polyvinyl Chloride (PVC)

    • Polyolefin

As per packaging type, the global parenteral packaging market is segmented as follows:

  • Small Volume Parenteral (SVP)

  • Large Volume Parenteral (LVP)

Competitive Landscape:

Key players operating in the global market for parenteral packaging include UFP Technologies, Inc., Schott AG, UDG Healthcare plc, Gerresheimer AG, Becton, Dickinson and Company, Catalent, Inc., Stevanato Group S.p.A., Baxter International Inc., Nipro Corporation, West Pharmaceutical Services, Inc., among others among others.

In this report, Future Market Insights (FMI) offers a 10-year forecast of the global parenteral packaging market between 2018 and 2028. In terms of value, the market is expected to expand at a CAGR of 4.8% over the forecast period. The study reveals market dynamics in seven geographic segments along with market analysis for current market environment and future scenario over the forecast period.

Report Description

This Future Market Insights report studies the global parenteral packaging market for the period 2018–2028. The prime objective of this report is to offer insights and key market trends pertaining to the global parenteral packaging market that are gradually helping transform global businesses.

The market numbers have been assessed on the basis of consumption and weighted average pricing of parenteral packaging on the basis of product type. The global parenteral packaging market report begins with the executive summary for various categories and their share in the parenteral packaging market. It is followed by market dynamics and overview of the global parenteral packaging market, which includes FMI analysis of market drivers, restraints, and trends that are affecting growth of the parenteral packaging market. Furthermore, to understand the popularity of the market segment, the attractiveness index and BPS analysis with elaborated insights on the same is provided, which will show the market’s attractiveness based on factors such as CAGR and incremental opportunity. To show the performance of the parenteral packaging market in each country and region, BPS and Y-o-Y growth analysis is provided.

The global market for parenteral packaging is segmented as per product type, material type, and packaging type. As per product type, global market for parenteral packaging is segmented into vials, pre-filled syringes & cartridges, bags, ampoules, and ready to use systems. On the basis of material type, the global parenteral packaging market is segmented into glass and plastic. Plastic segment is further sub – segmented in to Polyvinyl Chloride (PVC) and polyolefin. In addition, based on the packaging type, the global parenteral packaging market is segmented into Small Volume Parenteral (SVP), and Large Volume Parenteral (LVP).

The next section of the report highlights the parenteral packaging market, by region, and provides the market outlook for 2018 – 2028. The study investigates the Y-o-Y growth regionally, as well as analyses the drivers that influence the regional parenteral packaging market. Main regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia - Pacific excluding Japan, the Middle East & Africa (MEA) and Japan. The report evaluates the present scenario and growth prospects of the regional parenteral packaging market for 2018 – 2028.

To ascertain the market size in terms of value and volume, revenue generated by the key manufacturers and their respective production capacity is taken into consideration. The forecast presented here assesses the total revenue generated by value, across the parenteral packaging market. In order to provide an accurate forecast, we initiated by sizing up the current market, which forms the basis on how the parenteral packaging market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis; based on supply side, downstream industry demand and the economic envelope. In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse the market based on key parameters, such as year-on-year (Y-o-Y) growth rates, to understand the predictability of the parenteral packaging market and identify the right opportunities across the market.

The market segment for global parenteral packaging market have been analysed in terms of basis point share (BPS) to understand the individual segment’s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the parenteral packaging market. Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. Absolute dollar opportunity is critical for evaluating the scope of opportunity that a provider can look to achieve, as well as to identify potential resources from a delivery perspective of the parenteral packaging market. The overall absolute dollar opportunity along with the segmental split is mentioned in the report.

To understand key growth segments in terms of growth and adoption for parenteral packaging globally, Future Market Insights developed the parenteral packaging market ‘Attractiveness Index.’ The resulting index should help providers identify real market opportunities.

In the final section of the report on parenteral packaging, the ‘dashboard view’ of the companies is provided to compare the current industrial scenario and their contribution in total parenteral packaging market. Moreover, it is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on the in-depth assessment of their capabilities and success in the parenteral packaging marketplace.

Detailed profiles of companies are also included in the report to evaluate their strategies, key product offerings and recent developments. Key players operating in the global market for parenteral packaging include UFP Technologies, Inc., Schott AG, UDG Healthcare plc, Gerresheimer AG, Becton, Dickinson and Company, Catalent, Inc., Stevanato Group S.p.A., Baxter International Inc., Nipro Corporation, West Pharmaceutical Services, Inc., among others among others.

Key Segments Covered

By Product Type

  • Vials

  • Pre-filled Syringes & Cartridges

  • Bags

  • Ampoules

  • Ready to Use Systems

By Material Type

  • Glass

  • Plastic

    • Polyvinyl Chloride (PVC)

    • Polyolefin

By Packaging Type

  • Small Volume Parenteral (SVP)

  • Large Volume Parenteral (LVP)

Regional analysis is presented for following market segments:

  • North America

    • U.S.

    • Canada

  • Latin America

    • Brazil

    • Mexico

    • Rest of Latin America

  • Western Europe

    • Germany

    • Spain

    • Italy

    • U.K.

    • France

    • Benelux

    • Nordic

    • Rest of Western Europe

  • Eastern Europe

    • Russia

    • Poland

    • Rest of Eastern Europe

  • Asia Pacific Excluding Japan (APEJ)

    • China

    • India

    • ASEAN

    • Australia and New Zealand

    • Rest of APEJ

  • Middle East and Africa (MEA)

    • GCC

    • South Africa

    • Rest of MEA

  • Japan

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Get in touch

Harish Tiwari

Global Head - Business Development

Akshay Godge

Client Partner - Global Business Development

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology